Celularity Inc. (CELU)

NASDAQ: CELU · Real-Time Price · USD

1.250

-0.010 (-0.79%)

At close: Jan 6, 2026, 4:00 PM EST

1.270

+0.020 (1.60%)

After-hours: Jan 6, 2026, 6:52 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Degenerative Disease	48.39M	Log In	Log In	Log In	Log In	Upgrade
Degenerative Disease Growth	179.24%	Log In	Log In	Log In	Log In	Upgrade
BioBanking	5.14M	Log In	Log In	Log In	Log In	Upgrade
BioBanking Growth	-5.53%	Log In	Log In	Log In	Log In	Upgrade
Cell Therapy	688.00K	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	54.22M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	138.11%	Log In	Log In	Log In	Log In	Upgrade